 Sabrina Spencer
Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle | 21 | 2025 | 600 | 4.740 |
Why?
| | Cyclin-Dependent Kinase 2 | 12 | 2025 | 36 | 4.410 |
Why?
| | Cellular Senescence | 3 | 2025 | 229 | 1.910 |
Why?
| | Cyclin E | 2 | 2025 | 23 | 1.700 |
Why?
| | Cell Proliferation | 12 | 2025 | 2529 | 1.580 |
Why?
| | DNA Replication | 5 | 2024 | 251 | 1.520 |
Why?
| | Cell Cycle Proteins | 5 | 2023 | 633 | 1.480 |
Why?
| | Single-Cell Analysis | 7 | 2025 | 367 | 1.460 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 8 | 2025 | 106 | 1.450 |
Why?
| | Oncogene Proteins | 2 | 2025 | 62 | 1.400 |
Why?
| | Cyclin-Dependent Kinases | 5 | 2025 | 122 | 1.340 |
Why?
| | MAP Kinase Signaling System | 3 | 2025 | 308 | 1.140 |
Why?
| | Cell Cycle Checkpoints | 3 | 2025 | 97 | 1.130 |
Why?
| | Histones | 3 | 2024 | 672 | 1.130 |
Why?
| | Protein Kinase Inhibitors | 3 | 2025 | 984 | 1.120 |
Why?
| | Proto-Oncogene Proteins B-raf | 3 | 2025 | 230 | 1.030 |
Why?
| | Cyclin D1 | 2 | 2025 | 64 | 1.020 |
Why?
| | Melanoma | 2 | 2025 | 774 | 0.970 |
Why?
| | Neoplasms | 5 | 2025 | 2946 | 0.910 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2025 | 74 | 0.910 |
Why?
| | Retinoblastoma Protein | 4 | 2025 | 62 | 0.900 |
Why?
| | Signal Transduction | 11 | 2025 | 5272 | 0.880 |
Why?
| | Time-Lapse Imaging | 2 | 2025 | 21 | 0.860 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2025 | 174 | 0.860 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2025 | 138 | 0.850 |
Why?
| | Cell Line, Tumor | 11 | 2025 | 3565 | 0.840 |
Why?
| | CDC2-CDC28 Kinases | 1 | 2023 | 16 | 0.810 |
Why?
| | Mitosis | 4 | 2024 | 194 | 0.710 |
Why?
| | DNA Damage | 3 | 2024 | 440 | 0.680 |
Why?
| | Models, Biological | 7 | 2018 | 1772 | 0.660 |
Why?
| | Mitogens | 2 | 2020 | 55 | 0.650 |
Why?
| | Cell Tracking | 1 | 2020 | 18 | 0.640 |
Why?
| | G2 Phase | 1 | 2020 | 39 | 0.620 |
Why?
| | G1 Phase | 1 | 2020 | 65 | 0.610 |
Why?
| | Ovarian Neoplasms | 1 | 2025 | 599 | 0.590 |
Why?
| | Cell Survival | 5 | 2025 | 1111 | 0.580 |
Why?
| | Microscopy, Fluorescence | 1 | 2020 | 409 | 0.570 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 120 | 0.540 |
Why?
| | Proteolysis | 1 | 2018 | 173 | 0.520 |
Why?
| | Cell Line | 9 | 2025 | 2832 | 0.510 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 5 | 2013 | 54 | 0.510 |
Why?
| | Cell Division | 5 | 2023 | 758 | 0.490 |
Why?
| | Apoptosis | 5 | 2013 | 2454 | 0.480 |
Why?
| | Neuroblastoma | 1 | 2017 | 177 | 0.460 |
Why?
| | DNA | 2 | 2023 | 1444 | 0.450 |
Why?
| | Stem Cells | 1 | 2020 | 630 | 0.450 |
Why?
| | Stress, Physiological | 2 | 2025 | 445 | 0.450 |
Why?
| | Cyclin-Dependent Kinase 4 | 2 | 2025 | 53 | 0.420 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2025 | 889 | 0.410 |
Why?
| | S Phase | 2 | 2024 | 78 | 0.400 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2006 | 340 | 0.390 |
Why?
| | Gene Expression Regulation | 2 | 2025 | 2625 | 0.380 |
Why?
| | Hydrogels | 3 | 2025 | 706 | 0.360 |
Why?
| | Humans | 35 | 2025 | 147265 | 0.360 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2025 | 1457 | 0.360 |
Why?
| | Algorithms | 1 | 2020 | 1868 | 0.360 |
Why?
| | Breast Neoplasms | 1 | 2024 | 2420 | 0.330 |
Why?
| | Polyethylene Glycols | 3 | 2025 | 649 | 0.320 |
Why?
| | Up-Regulation | 2 | 2021 | 848 | 0.270 |
Why?
| | Neovascularization, Pathologic | 2 | 2006 | 287 | 0.260 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2025 | 180 | 0.260 |
Why?
| | Transcriptome | 2 | 2025 | 1059 | 0.250 |
Why?
| | Phosphorylation | 4 | 2025 | 1721 | 0.240 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 536 | 0.240 |
Why?
| | Caspases | 4 | 2013 | 233 | 0.230 |
Why?
| | Nuclear Proteins | 2 | 2023 | 745 | 0.220 |
Why?
| | Etoposide | 1 | 2025 | 169 | 0.220 |
Why?
| | Cyclin-Dependent Kinase 6 | 1 | 2025 | 49 | 0.220 |
Why?
| | Carbonates | 1 | 2025 | 13 | 0.220 |
Why?
| | Transcription Factor TFIIH | 1 | 2025 | 40 | 0.210 |
Why?
| | Carbamates | 1 | 2025 | 51 | 0.210 |
Why?
| | Esters | 1 | 2025 | 71 | 0.210 |
Why?
| | Systems Biology | 1 | 2004 | 68 | 0.200 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2025 | 264 | 0.200 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2023 | 64 | 0.200 |
Why?
| | Models, Genetic | 1 | 2006 | 536 | 0.200 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 109 | 0.200 |
Why?
| | Cell Differentiation | 3 | 2021 | 2054 | 0.200 |
Why?
| | Neoplasm Proteins | 1 | 2006 | 445 | 0.190 |
Why?
| | Leucine | 1 | 2023 | 116 | 0.190 |
Why?
| | Chromatin | 2 | 2024 | 561 | 0.190 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 443 | 0.190 |
Why?
| | Lysine | 2 | 2023 | 305 | 0.190 |
Why?
| | Methionine | 1 | 2023 | 161 | 0.190 |
Why?
| | Feedback | 1 | 2023 | 181 | 0.180 |
Why?
| | Evolution, Molecular | 1 | 2006 | 502 | 0.180 |
Why?
| | Oncogenes | 1 | 2023 | 118 | 0.180 |
Why?
| | Gene Regulatory Networks | 1 | 2025 | 318 | 0.180 |
Why?
| | Transcription Factors | 3 | 2025 | 1747 | 0.180 |
Why?
| | Azides | 1 | 2022 | 49 | 0.180 |
Why?
| | Animals | 11 | 2025 | 38416 | 0.180 |
Why?
| | Cell Lineage | 2 | 2021 | 381 | 0.170 |
Why?
| | RNA Polymerase II | 1 | 2025 | 350 | 0.170 |
Why?
| | Receptors, Glucocorticoid | 1 | 2023 | 132 | 0.170 |
Why?
| | Mitochondrial Membranes | 3 | 2011 | 40 | 0.170 |
Why?
| | Activating Transcription Factor 4 | 1 | 2021 | 22 | 0.170 |
Why?
| | Research Report | 1 | 2021 | 89 | 0.170 |
Why?
| | Dexamethasone | 1 | 2023 | 368 | 0.160 |
Why?
| | Cellular Reprogramming | 1 | 2021 | 98 | 0.160 |
Why?
| | Embryonic Development | 1 | 2021 | 125 | 0.160 |
Why?
| | Mice | 4 | 2025 | 18493 | 0.160 |
Why?
| | Cyclin D | 1 | 2020 | 8 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1794 | 0.150 |
Why?
| | Mutagenesis | 1 | 2021 | 196 | 0.150 |
Why?
| | Congresses as Topic | 1 | 2021 | 227 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 126 | 0.150 |
Why?
| | Amino Acids | 1 | 2023 | 519 | 0.150 |
Why?
| | Biomarkers | 2 | 2023 | 4354 | 0.140 |
Why?
| | Biosensing Techniques | 1 | 2020 | 142 | 0.140 |
Why?
| | MCF-7 Cells | 1 | 2018 | 133 | 0.140 |
Why?
| | Mutation | 3 | 2023 | 4130 | 0.130 |
Why?
| | Contact Inhibition | 1 | 2017 | 5 | 0.130 |
Why?
| | N-Myc Proto-Oncogene Protein | 1 | 2017 | 11 | 0.130 |
Why?
| | Cell Movement | 2 | 2020 | 966 | 0.130 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 330 | 0.130 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 452 | 0.130 |
Why?
| | Cdh1 Proteins | 1 | 2016 | 2 | 0.120 |
Why?
| | Anaphase-Promoting Complex-Cyclosome | 1 | 2016 | 12 | 0.120 |
Why?
| | Time Factors | 3 | 2020 | 7173 | 0.120 |
Why?
| | RNA, Messenger | 1 | 2023 | 2812 | 0.110 |
Why?
| | Myogenin | 1 | 2014 | 15 | 0.110 |
Why?
| | 3T3 Cells | 1 | 2013 | 157 | 0.100 |
Why?
| | fas Receptor | 1 | 2013 | 91 | 0.090 |
Why?
| | Permeability | 2 | 2009 | 170 | 0.090 |
Why?
| | Transcription, Genetic | 3 | 2025 | 1456 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 286 | 0.080 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 187 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2009 | 762 | 0.080 |
Why?
| | HeLa Cells | 2 | 2009 | 633 | 0.080 |
Why?
| | Pharmacological Phenomena | 1 | 2009 | 1 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2012 | 1225 | 0.080 |
Why?
| | Cells | 1 | 2009 | 25 | 0.070 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 11 | 0.070 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 31 | 0.070 |
Why?
| | Computer Simulation | 3 | 2012 | 1018 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2009 | 278 | 0.070 |
Why?
| | Probability | 1 | 2009 | 309 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 568 | 0.070 |
Why?
| | Female | 2 | 2025 | 80054 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2025 | 1253 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2013 | 4170 | 0.060 |
Why?
| | Computational Biology | 1 | 2010 | 677 | 0.050 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2024 | 12 | 0.050 |
Why?
| | Hydrolysis | 1 | 2025 | 197 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 223 | 0.050 |
Why?
| | Alkynes | 1 | 2022 | 67 | 0.040 |
Why?
| | Feedback, Physiological | 2 | 2014 | 80 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 372 | 0.040 |
Why?
| | Binding Sites | 1 | 2023 | 1319 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 708 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 537 | 0.040 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 209 | 0.030 |
Why?
| | Polymers | 1 | 2022 | 486 | 0.030 |
Why?
| | Proteomics | 1 | 2024 | 1205 | 0.030 |
Why?
| | RNA | 1 | 2023 | 916 | 0.030 |
Why?
| | F-Box Proteins | 1 | 2016 | 24 | 0.030 |
Why?
| | G1 Phase Cell Cycle Checkpoints | 1 | 2014 | 8 | 0.030 |
Why?
| | MyoD Protein | 1 | 2014 | 31 | 0.030 |
Why?
| | S-Phase Kinase-Associated Proteins | 1 | 2014 | 19 | 0.030 |
Why?
| | Bromodeoxyuridine | 1 | 2014 | 77 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2014 | 58 | 0.030 |
Why?
| | Ubiquitination | 1 | 2014 | 119 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1530 | 0.020 |
Why?
| | Stochastic Processes | 1 | 2013 | 65 | 0.020 |
Why?
| | Caspase Inhibitors | 1 | 2013 | 81 | 0.020 |
Why?
| | Phenotype | 2 | 2013 | 3216 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 376 | 0.020 |
Why?
| | Kinetics | 1 | 2014 | 1569 | 0.020 |
Why?
| | Base Sequence | 1 | 2014 | 2175 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2134 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2013 | 345 | 0.020 |
Why?
| | NF-kappa B | 1 | 2013 | 676 | 0.020 |
Why?
| | Apoptosomes | 1 | 2008 | 1 | 0.020 |
Why?
| | Drug Therapy | 1 | 2009 | 84 | 0.020 |
Why?
| | Caspase 8 | 1 | 2008 | 48 | 0.020 |
Why?
| | Organ Specificity | 1 | 2009 | 310 | 0.020 |
Why?
| | Caspase 9 | 1 | 2008 | 55 | 0.020 |
Why?
| | Protein Binding | 1 | 2014 | 2249 | 0.020 |
Why?
| | Cell Death | 1 | 2010 | 383 | 0.020 |
Why?
| | Caspase 3 | 1 | 2008 | 242 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1798 | 0.010 |
Why?
| | Proteins | 1 | 2009 | 1024 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2921 | 0.010 |
Why?
|
|
Spencer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|